Alan Musso
2023
In 2023, Alan Musso earned a total compensation of $1.9M as Chief Financial Officer at Fulcrum Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $61,700 |
|---|---|
| Option Awards | $1,605,754 |
| Salary | $180,682 |
| Other | $31,697 |
| Total | $1,879,833 |
Musso received $1.6M in option awards, accounting for 85% of the total pay in 2023.
Musso also received $61.7K in non-equity incentive plan, $180.7K in salary and $31.7K in other compensation.
Rankings
In 2023, Alan Musso's compensation ranked 531st out of 2,277 executives tracked by ExecPay. In other words, Musso earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 531 out of 2,277 | 77th |
Division Manufacturing | 295 out of 1,244 | 76th |
Major group Chemicals And Allied Products | 205 out of 702 | 71st |
Industry group Drugs | 203 out of 673 | 70th |
Industry Pharmaceutical Preparations | 129 out of 487 | 74th |
Source: SEC filing on April 19, 2024.
Musso's colleagues
We found five more compensation records of executives who worked with Alan Musso at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
2023
Robert Gould
Fulcrum Therapeutics